Related Experiment Video
Updated: Apr 26, 2026

09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.2K
Quantum study of boron nitride nanotubes functionalized with anticancer molecules
Eric Duverger1, Tijani Gharbi, Eric Delabrousse
1Institut FEMTO-ST, 32 Avenue de l'Observatoire, 25044 Besançon, France.
Physical Chemistry Chemical Physics : PCCP
|July 30, 2014
Summary
Single wall boron nitride nanotubes (BNNTs) can interact with azomethine and anticancer drugs. DFT-D2 calculations reveal stable physisorption inside BNNTs, with chemisorption possible under specific conditions, preserving drug integrity.
Area of Science:
- Computational Chemistry
- Materials Science
- Nanotechnology
Background:
- Boron Nitride Nanotubes (BNNTs) offer unique electronic and chemical properties.
- Investigating molecular interactions with BNNTs is crucial for developing novel applications.
- Understanding adsorption mechanisms is key for designing BNNT-based drug delivery systems.
Purpose of the Study:
- To investigate the interaction and adsorption behavior of azomethine and a platinum(IV) anticancer complex on single-wall (10,10) BNNTs.
- To determine the most stable configurations for molecular attachment on BNNTs.
- To assess the impact of molecular attachment on the integrity of the anticancer agent.
Main Methods:
- Density Functional Theory (DFT) with DFT-D2 dispersion corrections was employed.
- Calculations focused on the (10,10) BNNT interacting with azomethine and a Pt(IV) complex-amino derivative.
- Geometry optimization considered various configurations on both inner and outer nanotube surfaces.
Main Results:
- The most stable adsorption state for both molecules was found to be physisorption inside the BNNT in a parallel configuration.
- Chemisorption of azomethine was observed only when positioned over adjacent Boron and Nitrogen atoms.
- The attachment of molecules did not disrupt the cycloaddition process or affect the therapeutic agent's structure.
Conclusions:
- BNNTs can effectively host small molecules and drug complexes through physisorption and specific chemisorption.
- The structural integrity of the anticancer agent is maintained upon attachment to BNNTs.
- These findings support the potential of BNNTs as carriers for drug delivery systems.
Related Concept Videos
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Drugs that Destabilize Microtubules
3.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K

